Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 216

Sort by

Sort Order Select

Journal Articles

Direct Visualization of Platelet Integrins Using ANTI-Transmembrane Domain Peptides Containing a BLUE Fluorescent Amino Acid

Karen Pei Yi Fong, PhD BS, Ismail A. Ahmed, PhD, Marco Mravic, B.S., M.S., Hyunil Jo, PhD, William F. DeGrado, PhD, Feng Gai, PhD, Joel S. Bennett, MD

Blood (2019) 134 (Supplement_1): 2344.

https://doi.org/10.1182/blood-2019-128363

Published: 2019

Journal Articles

Increased Release of Soluble MD-2 in Sickle Cell Disease and Its Role in Pro-Inflammatory Signaling in Endothelial Cells

Ping Zhang, PhD, John D Belcher, PhD, Julia Nguyen, Fuad Abdulla, Gregory M Vercellotti, MD

Blood (2019) 134 (Supplement_1): 208.

https://doi.org/10.1182/blood-2019-122912

Published: 2019

Journal Articles

CTX-8573, an Innate-Cell Engager Targeting BCMA, is a Highly Potent Multispecific Antibody for the Treatment of Multiple Myeloma

Blood (2019) 134 (Supplement_1): 3182.

https://doi.org/10.1182/blood-2019-128749

Published: 2019

Journal Articles

Preclinical and Nonclinical Characterization of HPN217: A Tri-Specific T Cell Activating Construct (TriTAC) Targeting B Cell Maturation Antigen (BCMA) for the Treatment of Multiple Myeloma

Che-Leung Law, BSc,PhD, Wade Aaron, Rick Austin, Manasi Barath, Evan Callihan, Thomas Evans, Maria Gamez Guerrero, Golzar Hemmati, Adrie Jones, Kathryn Kwant, Llewelyn Lao, Bryan Lemon, Katrine Moldt, Purbasa Patnaik, Kenneth Sexton, Holger Wesche, Yinghua Xiao, Stephen Yu, Tim Yu

Blood (2018) 132 (Supplement 1): 3225.

https://doi.org/10.1182/blood-2018-99-113921

Published: 2018

Journal Articles

O -Fucose and Fringe-Modified Recombinant Notch Peptides As Decoy Molecules to Promote Hematopoietic Progenitor Mobilization

Lan Zhou, MD, Shuiliang Yu, PhD, Weihuan Wang, MD PhD, Marwah Albakri, Seunghwan Lim, Chris Siebel, PhD BA, Hillard M Lazarus, MD, John Letterio, MD, Wei Xin, MD PhD

Blood (2017) 130 (Supplement 1): 1903.

https://doi.org/10.1182/blood.V130.Suppl_1.1903.1903

Published: 2017

Journal Articles

Unique Transmembrane Domain Interactions Differentially Modulate Platelet αIIbβ3 and αvβ3 Function

Rustem I. Litvinov, MD PhD, Marco Mravic, B.S., M.S., Hua Zhu, BS, John W. Weisel, PhD, William F. DeGrado, PhD, Joel S. Bennett, MD

Blood (2017) 130 (Supplement 1): 1019.

https://doi.org/10.1182/blood.V130.Suppl_1.1019.1019

Published: 2017

Journal Articles

Novel Bispecific Antibody Targeting CD45 and 90 Y-DOTA Is Effective Therapy for Acute Myeloid Leukemia in Preclinical Murine Models

Johnnie J. Orozco, MD PhD, Aimee Kenoyer, BS, Yukang Lin, PhD, Darrell R. Fisher, PhD, Donald K. Hamlin, BS, D. Scott Wilbur, PhD, Alexandra Hernandez, BS, Rosario Guel, Margaret E. Nartea, Shyril O'Steen, PhD, Mark D Hylarides, PhD, Brian G Till, MD, Damian J. Green, MD, Ajay K. Gopal, MD, Kelly D Orcutt, PhD, Karl Dane Wittrup, PhD, Brenda M. Sandmaier, MD, John M. Pagel, MD PhD, Oliver W. Press, MD PhD

Blood (2017) 130 (Supplement 1): 1355.

https://doi.org/10.1182/blood.V130.Suppl_1.1355.1355

Published: 2017

Journal Articles

Anatomy of the Extracellular Clasps That Regulate Platelet αIIbβ3 and αvβ3 Function

Alex Sternisha, BS, Karen Pei Yi Fong, PhD BS, Joanna S. Slusky, PhD, Kyungchul Yoon, Joel S. Bennett, MD

Blood (2017) 130 (Supplement 1): 1022.

https://doi.org/10.1182/blood.V130.Suppl_1.1022.1022

Published: 2017

Journal Articles

Identification of Interacting Hot Spots in the αIIb Extracellular Stalk By Computational Alanine Scanning

Karen P Fong, PhD, Joanna Slusky, PhD, Kyungchul Yoon, Joel S. Bennett, MD

Blood (2016) 128 (22): 2531.

https://doi.org/10.1182/blood.V128.22.2531.2531

Published: 2016

Journal Articles

The Macrophage-Specific CD163 Is an Endocytic Receptor for Von Willebrand Factor (VWF) Cleaving Protease ADAMTS13

Fabian Verbij, MSc, Nicoletta Sorvillo, PhD, Paul Kaijen, Johana Hrdinova, MSc, Rob Fijnheer, MD PhD, Anja ten Brinke, PhD, Alexander B. Meijer, PhD, Floris P. van Alphen, BSc, Timo K. van der Berg, Dr., Jonas H. Graversen, Soren K. Moestrup, MD PhD, Jan Voorberg, PhD

Blood (2016) 128 (22): 17.

https://doi.org/10.1182/blood.V128.22.17.17

Published: 2016

Journal Articles

Structural and Functional Characterization of a Codon Optimized Coagulation Factor VIII

Svetlana A Shestopal, PhD, James H Kurasawa, MS, Jian-Jiang Hao, PhD, Elena Karnaukhova, PhD, Yideng Liang, PhD, Min Lin, PhD, Mikhail V Ovanesov, PhD, Timothy K Lee, PhD, John H McVey, PhD, Andrey G Sarafanov, PhD

Blood (2016) 128 (22): 3765.

https://doi.org/10.1182/blood.V128.22.3765.3765

Published: 2016

Journal Articles

Differential Glycosylation Between Recombinant Factor VIII Produced in Baby Hamster Kidney and Chinese Hamster Ovary Cells Confers Differences in Immunogenicity in a Humanized Hemophilia Α Mouse Model

Jesse Lai, BSc, Laura L Swystun, PhD, Dominique Cartier, Cunjie Zhang, MSc, Kate Nesbitt, James Dennis, PhD, Christine Hough, PhD, David Lillicrap, MD

Blood (2016) 128 (22): 326.

https://doi.org/10.1182/blood.V128.22.326.326

Published: 2016

Journal Articles

Molecular Basis for the Pro-Thrombotic Activity of Von Willebrand Factor Under Inflammatory Conditions

Rachel Tsai, Yiming Li, Olga Yakovenko, PhD, An-Yue Tu, PhD, Nichole S. Tyler, Gianluca Interlandi, PhD

Blood (2016) 128 (22): 554.

https://doi.org/10.1182/blood.V128.22.554.554

Published: 2016

Journal Articles

A Short N-Terminal Fragment in Front of the A1 Domain of Von Willebrand Factor Prevents the A1 from Binding the Platelet By Masking a Region Clustered By Type 2B VWD Mutations

Wei Deng, PhD, Yingchun Wang, PhD, Pete Lollar, MD, Renhao Li, PhD

Blood (2016) 128 (22): 553.

https://doi.org/10.1182/blood.V128.22.553.553

Published: 2016

Journal Articles

Asymptomatic Dysprothrombinemia (Prothtombin Himi) with p.M380T and p.R431H Shows Severely Reduced Clotting Activity, Moderate Antithrombin Resistance and Severe Thrombomodulin Binding Defect

Eriko Morishita, MD PhD, Mao Takata, BSc, Fumina Taniguchi, BSc, Masashi Akiyama, PhD, Akiko Sekiya, PhD, Akira Takagi, PhD, Toshiyuki Miyata, PhD, Tetsuhito Kojima, MD PhD

Blood (2016) 128 (22): 2574.

https://doi.org/10.1182/blood.V128.22.2574.2574

Published: 2016

Journal Articles

CD38 and Antibody Therapy: What Can Basic Science Add?

Fabio Malavasi, MD, Antonella Chillemi, PhD, Barbara Castella, PhD, Ilaria Schiavoni, PhD, Danny Incarnato, PhD, Stefania Oliva, MD, Alberto L Horenstein, PhD

Blood (2016) 128 (22): SCI-36.

https://doi.org/10.1182/blood.V128.22.SCI-36.SCI-36

Published: 2016

Journal Articles

Development of Novel Human Anti-HLA-Monoclonal Antibodies for Clinical Applications Using Peripheral Blood B Cells Derived from Anti-HLA Antibody-Positive Donors

Hiroyuki Takamatsu, MD PhD, Yoshitaka Zaimoku, MD, Tatsuhiko Ozawa, PhD, Shintaro Kawai, PhD, Hidenori Tanaka, Phar.B., Hiroyuki Kishi, PhD, Atsushi Muraguchi, MD PhD, Shinji Nakao, MD PhD

Blood (2016) 128 (22): 4723.

https://doi.org/10.1182/blood.V128.22.4723.4723

Published: 2016

Journal Articles

ZW38, a Novel Azymetric Bispecific CD19-Directed CD3 T Cell Engager Antibody Drug Conjugate with Controlled T Cell Activation and Improved B Cell Cytotoxicity

Gordon Ng, PhD MSc, BSc, Thomas Spreter, PhD, Rupert Davies, PhD, Grant Wickman, PhD

Blood (2016) 128 (22): 1841.

https://doi.org/10.1182/blood.V128.22.1841.1841

Published: 2016

Journal Articles

Rivipansel: A Small Pan-Selectin Antagonist Improves Cerebral Perfusion and Inhibits Leukocyte Adhesion and in Murine Sickle Cell Disease Model

Reema Jasuja, Georgette Suidan, Sunita Patel Hett, Kunal Desai, Kevin X Le, Elizabeth Parks, Robert Bell, John E. Murphy, Debra D Pittman

Blood (2016) 128 (22): 270.

https://doi.org/10.1182/blood.V128.22.270.270

Published: 2016

Journal Articles

A Novel Bispecific CD38 Antibody Eradicates Multiple Myeloma in a Mouse Model Following Yttrium-90-DOTA Capture

Blood (2015) 126 (23): 118.

https://doi.org/10.1182/blood.V126.23.118.118

Published: 2015

NARROW

Direct Visualization of Platelet Integrins Using ANTI-Transmembrane Domain Peptides Containing a BLUE Fluorescent Amino Acid

Increased Release of Soluble MD-2 in Sickle Cell Disease and Its Role in Pro-Inflammatory Signaling in Endothelial Cells

CTX-8573, an Innate-Cell Engager Targeting BCMA, is a Highly Potent Multispecific Antibody for the Treatment of Multiple Myeloma

Preclinical and Nonclinical Characterization of HPN217: A Tri-Specific T Cell Activating Construct (TriTAC) Targeting B Cell Maturation Antigen (BCMA) for the Treatment of Multiple Myeloma

O -Fucose and Fringe-Modified Recombinant Notch Peptides As Decoy Molecules to Promote Hematopoietic Progenitor Mobilization

Unique Transmembrane Domain Interactions Differentially Modulate Platelet αIIbβ3 and αvβ3 Function

Novel Bispecific Antibody Targeting CD45 and 90 Y-DOTA Is Effective Therapy for Acute Myeloid Leukemia in Preclinical Murine Models

Anatomy of the Extracellular Clasps That Regulate Platelet αIIbβ3 and αvβ3 Function

Identification of Interacting Hot Spots in the αIIb Extracellular Stalk By Computational Alanine Scanning

The Macrophage-Specific CD163 Is an Endocytic Receptor for Von Willebrand Factor (VWF) Cleaving Protease ADAMTS13

Structural and Functional Characterization of a Codon Optimized Coagulation Factor VIII

Differential Glycosylation Between Recombinant Factor VIII Produced in Baby Hamster Kidney and Chinese Hamster Ovary Cells Confers Differences in Immunogenicity in a Humanized Hemophilia Α Mouse Model

Molecular Basis for the Pro-Thrombotic Activity of Von Willebrand Factor Under Inflammatory Conditions

A Short N-Terminal Fragment in Front of the A1 Domain of Von Willebrand Factor Prevents the A1 from Binding the Platelet By Masking a Region Clustered By Type 2B VWD Mutations

Asymptomatic Dysprothrombinemia (Prothtombin Himi) with p.M380T and p.R431H Shows Severely Reduced Clotting Activity, Moderate Antithrombin Resistance and Severe Thrombomodulin Binding Defect

CD38 and Antibody Therapy: What Can Basic Science Add?

Development of Novel Human Anti-HLA-Monoclonal Antibodies for Clinical Applications Using Peripheral Blood B Cells Derived from Anti-HLA Antibody-Positive Donors

ZW38, a Novel Azymetric Bispecific CD19-Directed CD3 T Cell Engager Antibody Drug Conjugate with Controlled T Cell Activation and Improved B Cell Cytotoxicity

Rivipansel: A Small Pan-Selectin Antagonist Improves Cerebral Perfusion and Inhibits Leukocyte Adhesion and in Murine Sickle Cell Disease Model

A Novel Bispecific CD38 Antibody Eradicates Multiple Myeloma in a Mouse Model Following Yttrium-90-DOTA Capture

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only